NASDAQ:SLGL Sol Gel Technologies Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sol Gel Technologies Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $7.15 -0.02 (-0.28 %) (As of 09/24/2020 12:00 AM ET) Add Compare Share Today's Range$7.06Now: $7.15▼$7.3750-Day Range$7.17MA: $7.71▼$8.3752-Week Range$5.00Now: $7.15▼$21.00Volume11,148 shsAverage Volume45,207 shsMarket Capitalization$145.79 millionP/E RatioN/ADividend YieldN/ABeta1.44 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include TWIN and SIRS-T, which has completed Phase II clinical trials for the treatment of acne vulgaris; and VERED that has completed Phase II clinical trials for the treatment of papulopustular rosacea. It is also involved in the development of generic dermatological drug products. Sol-Gel Technologies Ltd. has collaboration with Perrigo; and Douglas Pharmaceuticals for the development and commercialization of a generic product candidate. The company was founded in 1997 and is headquartered in Ness Ziona, Israel.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingSol Gel Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $25.25, Sol Gel Technologies has a forecasted upside of 253.1% from its current price of $7.15.Amount of Analyst CoverageSol Gel Technologies has only been the subject of 2 research reports in the past 90 days. Previous Next 2.3 Community Rank Outperform VotesSol Gel Technologies has received 127 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSol Gel Technologies has received 146 “underperform” votes. (Add your “underperform” vote.)Community SentimentSol Gel Technologies has received 53.48% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sol Gel Technologies and other stocks. Vote “Outperform” if you believe SLGL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SLGL will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSol Gel Technologies does not currently pay a dividend.Dividend GrowthSol Gel Technologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sol Gel Technologies insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 32.08% of the stock of Sol Gel Technologies is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Sol Gel Technologies are expected to decrease in the coming year, from ($1.57) to ($1.76) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sol Gel Technologies is -5.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sol Gel Technologies is -5.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSol Gel Technologies has a P/B Ratio of 2.78. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.16 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SLGL Previous Symbol CUSIPN/A CIK1684693 Webwww.sol-gel.com Phone972-8931-3429Debt Debt-to-Equity Ratio0.02 Current Ratio9.94 Quick Ratio9.94Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$22.90 million Price / Sales6.37 Cash FlowN/A Price / Cash FlowN/A Book Value$2.57 per share Price / Book2.78Profitability EPS (Most Recent Fiscal Year)($1.26) Net Income$-24,610,000.00 Net Margins-210.73% Return on Equity-46.18% Return on Assets-40.10%Miscellaneous EmployeesN/A Outstanding Shares20,390,000Market Cap$145.79 million Next Earnings Date11/11/2020 (Estimated) OptionableNot Optionable $7.15 -0.02 (-0.28 %) (As of 09/24/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive SLGL News and Ratings via Email Sign-up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Sol Gel Technologies (NASDAQ:SLGL) Frequently Asked Questions How has Sol Gel Technologies' stock price been impacted by Coronavirus (COVID-19)? Sol Gel Technologies' stock was trading at $8.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SLGL stock has decreased by 13.3% and is now trading at $7.15. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Sol Gel Technologies? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sol Gel Technologies in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sol Gel Technologies. When is Sol Gel Technologies' next earnings date? Sol Gel Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, November 11th 2020. View our earnings forecast for Sol Gel Technologies. How were Sol Gel Technologies' earnings last quarter? Sol Gel Technologies Ltd (NASDAQ:SLGL) issued its quarterly earnings results on Thursday, August, 6th. The company reported ($0.31) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.32) by $0.01. Sol Gel Technologies had a negative return on equity of 46.18% and a negative net margin of 210.73%. View Sol Gel Technologies' earnings history. What price target have analysts set for SLGL? 4 analysts have issued twelve-month price objectives for Sol Gel Technologies' stock. Their forecasts range from $21.00 to $33.00. On average, they anticipate Sol Gel Technologies' stock price to reach $25.25 in the next twelve months. This suggests a possible upside of 253.1% from the stock's current price. View analysts' price targets for Sol Gel Technologies. Who are some of Sol Gel Technologies' key competitors? Some companies that are related to Sol Gel Technologies include Eagle Pharmaceuticals (EGRX), Zafgen (ZFGN), Legend Biotech (CALT), Omeros (OMER), XBiotech (XBIT), Syndax Pharmaceuticals (SNDX), Axovant Sciences (AXON), Geron (GERN), Flexion Therapeutics (FLXN), ZIOPHARM Oncology (ZIOP), Vanda Pharmaceuticals (VNDA), Forte Biosciences (FBRX), Radius Health (RDUS), Molecular Templates (MTEM) and Clovis Oncology (CLVS). View all competitors. What other stocks do shareholders of Sol Gel Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sol Gel Technologies investors own include NVIDIA (NVDA), Iovance Biotherapeutics (IOVA), Teva Pharmaceutical Industries (TEVA), Adaptimmune Therapeutics (ADAP), Corbus Pharmaceuticals (CRBP), CorMedix (CRMD), Flexion Therapeutics (FLXN), TapImmune (MRKR), Tesla (TSLA) and Viking Therapeutics (VKTX). Who are Sol Gel Technologies' key executives? Sol Gel Technologies' management team includes the following people: Dr. Alon Seri-Levy, Co-Founder, CEO & Director (Age 58)Mr. Gilad Mamlok, Chief Financial Officer (Age 51)Mr. Itzik Yosef, VP of Operations (Age 43)Dr. Ofer Toledano, VP of R&D (Age 54)Dr. Ofra Levy-Hacham Ph.D., VP of Clinical & Regulatory Affairs (Age 53) When did Sol Gel Technologies IPO? (SLGL) raised $60 million in an IPO on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. Jefferies and BMO Capital Markets served as the underwriters for the IPO and JMP Securities and Raymond James were co-managers. What is Sol Gel Technologies' stock symbol? Sol Gel Technologies trades on the NASDAQ under the ticker symbol "SLGL." Who are Sol Gel Technologies' major shareholders? Sol Gel Technologies' stock is owned by a variety of retail and institutional investors. Top institutional investors include Harel Insurance Investments & Financial Services Ltd. (4.55%), Bank of Montreal Can (0.27%), Raymond James Financial Services Advisors Inc. (0.26%) and Canada Pension Plan Investment Board (0.05%). Which major investors are buying Sol Gel Technologies stock? SLGL stock was acquired by a variety of institutional investors in the last quarter, including Canada Pension Plan Investment Board, Raymond James Financial Services Advisors Inc., Harel Insurance Investments & Financial Services Ltd., and Bank of Montreal Can. How do I buy shares of Sol Gel Technologies? Shares of SLGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Sol Gel Technologies' stock price today? One share of SLGL stock can currently be purchased for approximately $7.15. How big of a company is Sol Gel Technologies? Sol Gel Technologies has a market capitalization of $145.79 million and generates $22.90 million in revenue each year. The company earns $-24,610,000.00 in net income (profit) each year or ($1.26) on an earnings per share basis. What is Sol Gel Technologies' official website? The official website for Sol Gel Technologies is www.sol-gel.com. How can I contact Sol Gel Technologies? Sol Gel Technologies' mailing address is 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403648. The company can be reached via phone at 972-8931-3429 or via email at [email protected] This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
